Herbal hope: new capsule aims to ease Opioid-Induced constipation in cancer patients
NCT ID NCT07534995
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a traditional Chinese medicine capsule, Shouhui Tongbian, to see if it can relieve constipation caused by opioid painkillers in cancer patients. About 270 adults with stable cancer and opioid-induced constipation will take either the capsule or a standard laxative (lactulose) for several weeks. The goal is to improve bowel movement frequency and quality of life, while also checking safety and exploring how the capsule affects gut bacteria.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Shouhui Tongbian Capsule (a traditional Chinese medicine)
- What this could lead to
- If it works, this could provide a new option to relieve constipation caused by opioid painkillers in cancer patients, improving their comfort and daily life.
- What could go wrong
- This is an early-stage Phase 3 trial with only 270 participants, so results may not apply to everyone. The capsule is a traditional Chinese medicine, and its effectiveness and safety compared to standard treatments like lactulose are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.